The regulatory mechanisms of TRIM3 are mainly due to the post-translational suppression of P53 protein function and sumoylation on estrogen receptor, which facilitate estrogen signaling and breast cancer proliferation [34, 35]. The gene discussed is TP53; the disease is breast carcinoma.